Get unlimited access to our best features
Subscribe now

U.S. Could Have Had Many More Doses of Monkeypox Vaccine This Year

Summary by Ground News
As of July 22, 223 people have been treated with the drug, compared with more than 6,000 known cases in the United States. The FDA approved TPOXX in 2018 for smallpox in adults and children. The European Medicines Agency said it expects side effects to be similar in infected people.
U.S. Could Have Had Many More Doses of Monkeypox Vaccine This Year
11 days ago·Washington, United States

News Articles

More Filters
All
Left
Center
Right
Reuters

U.S. regulators defend requiring more data on monkeypox drug

As U.S. monkeypox cases rise, U.S. health agencies in a medical journal article published on Wednesday defended their decision to require human trial data to show that SIGA Technologies' experimental drug TPOXX is safe and effective to treat the virus.

11 days ago·United Kingdom
Read Full Article
IBTimes

U.S. Regulators Defend Requiring More Data On Monkeypox Drug

As U.S. monkeypox cases rise, U.S. health agencies in a medical journal article published on Wednesday defended their decision to require human trial data to show that SIGA Technologies' experimental drug TPOXX is safe and effective to treat the virus.

11 days ago·United States
Read Full Article
New York Times

U.S. Could Have Had Many More Doses of Monkeypox Vaccine This Year

The Department of Health and Human Services delayed asking the manufacturer to process the bulk vaccine the government already owned into vials.

11 days ago·New York, United States
Read Full Article
HuffPost

U.S. Slow To Ask For Monkeypox Vaccines, Adding Months To Delivery Schedule: Report

Millions of vaccines on order likely won't be delivered until 2023.

11 days ago·United States
Read Full Article
Political Wire

U.S. Could Have Had Many More Doses of Monkeypox Vaccine

“The shortage of vaccines to combat a fast-growing monkeypox outbreak was caused in part because the Department of Health and Human Services failed early on to ask that bulk stocks of the vaccine it already owned be bottled for distribution,“ the New York Times reports.“By the time the federal government placed its orders, the vaccine’s Denmark-based manufacturer, Bavarian Nordic, had booked other clients and was unable to do the work for months…

11 days ago·New York, United States
Read Full Article
The Daily Beast

U.S. Dragged Feet on Getting Monkeypox Vax Into Vials: NYT

The government owns more than 16 million doses of the vaccine in bulk but failed to ask for it to be bottled for distribution quickly enough.

11 days ago·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

57% of the sources are Center
HuffPost
The Daily Beast
New York Times
Reuters
IBTimes
Political Wire
San Diego Union Tribune
L 43%
C 57%
See less detail